Comparison of Certolizumab Pegol Versus Adalimumab: 2 Year Efficacy and Safety Results from a Superiority, Investigator-Blind, Head-to-Head Study

被引：0

作者：

Fleischmann, Roy ^{[1
]}

Burmester, Gerd-Rudiger ^{[2
]}

Combe, Bernard ^{[3
]}

Curtis, Jeffrey R. ^{[4
]}

Hal, Stephen ^{[5
]}

Haraoui, Boulos ^{[6
]}

van Vollenhoven, Ronald ^{[7
]}

Cioffi, Christopher ^{[8
]}

Ecoffet, Cecile ^{[9
]}

Ionescu, Lucian ^{[9
]}

Gervitz, Leon ^{[10
]}

Peterson, Luke ^{[8
]}

Smolen, Josef ^{[11
,12
]}

机构：

[1] Univ Texas Southwestern Med Ctr Dallas, Metroplex Clin Res Ctr, Dallas, TX 75390 USA

[2] Charite Univ Med Berlin, Berlin, Germany

[3] Montpellier Univ Hosp, Montpellier, France

[4] Univ Alabama Birmingham, Div Clin Immunol & Rheumatol, Birmingham, AL USA

[5] Monash Univ, Cabrini Med Ctr, Melbourne, Vic, Australia

[6] Ctr Hosp Univ Montreal, Dept Med, Montreal, PQ, Canada

[7] Amsterdam Rheumatol & Immunol Ctr ARC, Amsterdam, Netherlands

[8] UCB Pharma, Raleigh, NC USA

[9] UCB Pharma, Brussels, Belgium

[10] UCB Pharma, RA Patient Value Mission, Brussels, Belgium

[11] Med Univ Vienna, Vienna, Austria

[12] Hietzing Hosp, Vienna, Austria

来源：

ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2987

引用

页数：3

共 50 条

[21] Safety of Microsurgery Under Loupes Versus Microscope A Head-to-Head Comparison of 2 Surgeons With Similar Experiences
Ehanire, Tosan
Singhal, Dhruv
Mast, Bruce
Leyngold, Mark
[J]. ANNALS OF PLASTIC SURGERY, 2018, 80 : S340 - S342
[22] VEDOLIZUMAB SHOWS SUPERIOR EFFICACY VERSUS ADALIMUMAB: RESULTS OF VARSITY-THE FIRST HEAD-TO-HEAD STUDY OF BIOLOGIC THERAPY FOR MODERATE-TO-SEVERE ULCERATIVE COLITIS
Sands, Bruce E.
Peyrin-Biroulet, Laurent
Loftus, Edward V.
Danese, Silvio
Colombel, Jean Frederic
Abhyankar, Brihad
Chen, Jingjing
Rogers, Raquel
Lirio, Richard A.
Bornstein, Jeffrey D.
Schreiber, Stefan
[J]. GASTROENTEROLOGY, 2019, 156 (06) : S81 - S81
[23] Efficacy of secukinumab and adalimumab in patients with psoriatic arthritis and concomitant moderate-to-severe plaque psoriasis: results from EXCEED, a randomized, double-blind head-to-head monotherapy study
Gottlieb, A. B.
Merola, J. F.
Reich, K.
Behrens, F.
Nash, P.
Griffiths, C. E. M.
Bao, W.
Pellet, P.
Pricop, L.
McInnes, I. B.
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (06) : 1124 - 1134
[24] Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: Findings of a phase IIIb, multinational, prospective, randomized study
Weinblatt, Michael E.
Schiff, Michael
Valente, Robert
van der Heijde, Desiree
Citera, Gustavo
Zhao, Cathy
Maldonado, Michael
Fleischmann, Roy
[J]. ARTHRITIS AND RHEUMATISM, 2013, 65 (01): : 28 - 38
[25] Patient-Reported Outcomes From a Two-Year Head-to-Head Comparison of Subcutaneous Abatacept and Adalimumab for Rheumatoid Arthritis
Fleischmann, Roy
Weinblatt, Michael E.
Schiff, Michael
Khanna, Dinesh
Maldonado, Michael A.
Nadkarni, Anagha
Furst, Daniel E.
[J]. ARTHRITIS CARE & RESEARCH, 2016, 68 (07) : 907 - 913
[26] Effect of Secukinumab Versus Adalimumab Biosimilar on Radiographic Progression in Patients With Radiographic Axial Spondyloarthritis: Results From a Head-to-Head Randomized Phase IIIb Study
Baraliakos, Xenofon
Ostergaard, Mikkel
Poddubnyy, Denis
van der Heijde, Desiree
Deodhar, Atul
Machado, Pedro M.
Navarro-Compan, Victoria
Hermann, Kay Geert A.
Kishimoto, Mitsumasa
Lee, Eun Young
Gensler, Lianne S.
Kiltz, Uta
Eigenmann, Marco F.
Pertel, Patricia
Readie, Aimee
Richards, Hanno B.
Porter, Brian
Braun, Juergen
[J]. ARTHRITIS & RHEUMATOLOGY, 2024, 76 (08) : 1278 - 1287
[27] Telbivudine versus Entecavir in Patients with Chronic Hepatitis B: 2-Year Results of a Head-To-Head Trial
Huang, Jing
Chen, Xiaoping
Chen, Xuefu
Chen, Re
Chen, Wenli
Ma, Xiaojun
Luo, Xiaodan
[J]. HEPATOLOGY, 2013, 58 : 681A - 681A
[28] Comparative Cost per Response for Four Clinical Outcomes of Tocilizumab Monotherapy Versus Adalimumab Monotherapy in a Head-to-Head Randomized Double-Blind Superiority Trial in Patients with Rheumatoid Arthritis
Best, Jennie H.
Pei, Jinglan
[J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
[29] Efficacy and safety of empagliflozin compared with glimepiride in South Asian patients with Type 2 diabetes in a head-to-head study
Khunti, K.
Bingham-Gardiner, P.
Hassan, S. W.
Zeller, C.
Naderali, E.
Salsali, A.
Hach, T.
[J]. DIABETIC MEDICINE, 2015, 32 : 96 - 96
[30] COMPARATIVE COST PER RESPONSE FOR FOUR CLINICAL OUTCOMES OF TOCILIZUMAB MONOTHERAPY VERSUS ADALIMUMAB MONOTHERAPY IN A HEAD-TO-HEAD RANDOMISED DOUBLE-BLIND SUPERIORITY TRIAL (ADACTA) IN PATIENTS WITH RHEUMATOID ARTHRITIS
Best, J.
Pei, J.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 521 - 521

← 1 2 3 4 5 →